Molecular interactions of dendrimers with amyloid peptides: pH dependence

被引:73
作者
Klajnert, B.
Cladera, J.
Bryszewska, M.
机构
[1] Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland
[2] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain
关键词
D O I
10.1021/bm060229s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The formation of amyloid plaques is a key pathological event in neurodegenerative disorders, such as prion and Alzheimer's diseases. Dendrimers are considered promising therapeutic agents in these disorders. In the present work, we have studied the effect of polypropyleneimine dendrimers on the formation of amyloid fibrils as a function of pH in order to gain further insight in the aggregation mechanism and its inhibition. Amyloid fibrils from prion peptide PrP 185-208 and Alzheimer's peptide A ss 1-28 were produced in vitro, and their formation was monitored using the dye thioflavin T (ThT). The results showed that the level of protonation of His, Glu, and Asp residues is important for the final effect, especially at low dendrimer concentration when their inhibiting capacity depends on the pH. At the highest concentrations, dendrimers were very effective against fibril formations for both prion and Alzheimer's peptides.
引用
收藏
页码:2186 / 2191
页数:6
相关论文
共 30 条
[1]  
BORROW CJ, 1991, SCIENCE, V253, P179
[2]   Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines [J].
Caughey, WS ;
Raymond, LD ;
Horiuchi, M ;
Caughey, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12117-12122
[3]   Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium [J].
El-Sayed, M ;
Kiani, MF ;
Naimark, MD ;
Hikal, AH ;
Ghandehari, H .
PHARMACEUTICAL RESEARCH, 2001, 18 (01) :23-28
[4]   Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications [J].
Esfand, R ;
Tomalia, DA .
DRUG DISCOVERY TODAY, 2001, 6 (08) :427-436
[5]   EFFECTS OF SULFATE-IONS ON ALZHEIMER-BETA/A4 PEPTIDE ASSEMBLIES - IMPLICATIONS FOR AMYLOID FIBRIL PROTEOGLYCAN INTERACTIONS [J].
FRASER, PE ;
NGUYEN, JT ;
CHIN, DT ;
KIRSCHNER, DA .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (04) :1531-1540
[6]   Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers [J].
Heegaard, PMH ;
Pedersen, HG ;
Flink, J ;
Boas, U .
FEBS LETTERS, 2004, 577 (1-2) :127-133
[7]   Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor [J].
Hollins, AJ ;
Benboubetra, M ;
Omidi, Y ;
Zinselmeyer, BH ;
Schatzlein, AG ;
Uchegbu, IF ;
Akhtar, S .
PHARMACEUTICAL RESEARCH, 2004, 21 (03) :458-466
[8]   STRUCTURE OF BETA-CRYSTALLITE ASSEMBLIES FORMED BY ALZHEIMER BETA-AMYLOID PROTEIN ANALOGS - ANALYSIS BY X-RAY-DIFFRACTION [J].
INOUYE, H ;
FRASER, PE ;
KIRSCHNER, DA .
BIOPHYSICAL JOURNAL, 1993, 64 (02) :502-519
[9]   Influence of dendrimer's structure on its activity against amyloid fibril formation [J].
Klajnert, B. ;
Cortijo-Arellano, M. ;
Cladera, J. ;
Bryszewska, M. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) :21-28
[10]   Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases [J].
Klajnert, B ;
Cortijo-Arellano, M ;
Bryszewska, M ;
Cladera, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (02) :577-582